Delivering on the promise of gene editing
Drug Discovery World
DECEMBER 15, 2022
While viral vectors can be highly active, they can lead to only transient expression (rAAV, AdV), can lead to adverse immune responses (AdV) or can integrate randomly into the genome (LV). In all cases, viral delivery vectors have limited payload capacity which can limit various use cases.
Let's personalize your content